Answers are grounded in this paper and cite their sources.
With the growing number of therapeutic options in inflammatory bowel disease (IBD), decisions related to long-term disease management are increasingly preference-sensitive. In these decisions, shared decision making (SDM) is recommended to align treatment decisions with patient values, yet practical tools to support SDM in IBD remain limited. This study aimed to systematically develop and alpha-test a patient decision aid (PtDA) for preference-sensitive IBD treatment decisions within the Belgian healthcare context. A multi-phase, user-centered development process was conducted in line with International Patient Decision Aid Standards (IPDAS) guidance. First, decisional needs were explored through semi-structured interviews with IBD patients ( n = 15) and healthcare professionals ( n = 23) to define scope and content. Second, an evidence-informed digital prototype was developed, incorporating a discrete choice experiment (DCE) as a values clarification exercise. Third, iterative alpha testing was conducted with patients ( n = 17) and healthcare professionals ( n = 18) using think-aloud sessions, usability questionnaires, and interviews. Qualitative and quantitative findings informed iterative refinements. Needs assessment identified initiation or switching of advanced therapies as a key preference-sensitive decision, which defined the PtDA scope. The resulting web-based PtDA, I(BD) SELECT, provides tailored treatment information and generates a personalized preference summary based on DCE responses. Alpha testing showed good usability (mean System Usability Scale score 78.9/100). Participants valued the balanced information and personalized summary, reporting that it could improve their preparation for consultations and support reflection on their preferences. Suggested refinements focused mainly on wording and navigation and were incorporated iteratively. Most participants indicated willingness to use the PtDA in practice. I(BD) SELECT was systematically developed and was rated as usable and acceptable in alpha testing among patients and healthcare professionals. By combining tailored information with structured preference elicitation, it shows promise for supporting SDM in IBD care. Field testing is ongoing to evaluate its effectiveness, feasibility, and impact in routine clinical practice.
No takes yet. Share an insight, caveat, or question.
Schoefs et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: